Glaser K B, Lock Y W
Inflammatory Diseases Division, Wyeth-Ayerst Research, Princeton, NJ 08543, USA.
Biochem Pharmacol. 1995 Sep 28;50(7):913-22. doi: 10.1016/0006-2952(95)00211-h.
The marine natural products manoalide and scalaradial are potent anti-inflammatory agents that inactivate the enzyme phospholipase A2 (PLA2) in vitro. To study the mechanism of inhibition of prostaglandin E2 (PGE2) production in human monocytes by manoalide and scalaradial, lipopolysaccharide (LPS)-induced prostaglandin biosynthesis and induction of prostaglandin H synthase (PGHS) were evaluated. LPS (10 ng/mL) and interleukin-1 beta (IL-1 beta, 50-1000 ng/mL) but not tumor necrosis factor alpha (TNF alpha, 300 ng/mL) induced the expression of the PGHS-2 isoform as determined by immunoblot analysis with a specific polyclonal antibody for PGHS-2. Manoalide and scalaradial (1-10 microM) inhibited LPS-induced endogeneous PGE2 production, reduced the LPS-induced PGHS activity, and reduced the expression of PGHS-2. Indomethacin [a PGHS inhibitor (0.01 to 0.1 microM)], zileuton [a 5-lipoxygenase inhibitor (3-10 microM)], and WEB-2806 [a platelet-activating factor (PAF) antagonist (30 microM)] did not affect the LPS-induced expression of PGHS-2 in human monocytes. These results suggest that modulation of lipid mediator production by manoalide or scalaradial may not be involved in the observed effects on the expression of PGHS-2. Manoalide and scalaradial also inhibited the release of IL-1 beta and TNF alpha from LPS-stimulated monocytes. Expression of PGHS-2 induced by either LPS or IL-1 beta was blocked by the IL-1 receptor antagonist (IL-1ra, 2 micrograms/mL) but not by rolipram, a phosphodiesterase IV inhibitor that inhibits TNF alpha but not IL-1 beta release. Similar to LPS, IL-1 beta-induced PGHS-2 expression was apparently not regulated by lipid mediators such as prostaglandins, leukotrienes or PAF as determined with specific inhibitors and antagonists. Scalaradial and to some extent manoalide were capable of blocking the IL-1 beta-induced expression of PHGS-2. These results indicate that IL-1 beta is the predominant cytokine responsible for the induction of PGHS-2 in the human monocyte. Furthermore, marine natural products such as scalaradial have novel effects on the IL-1 beta-mediated induction of PGHS-2 in human monocytes, which appears to be independent of effects on lipid mediator production.
海洋天然产物 manoalide 和 scalaradial 是强效抗炎剂,它们在体外可使磷脂酶 A2(PLA2)失活。为了研究 manoalide 和 scalaradial 抑制人单核细胞中前列腺素 E2(PGE2)产生的机制,对脂多糖(LPS)诱导的前列腺素生物合成及前列腺素 H 合酶(PGHS)的诱导进行了评估。用针对 PGHS-2 的特异性多克隆抗体通过免疫印迹分析确定,LPS(10 ng/mL)和白细胞介素-1β(IL-1β,50 - 1000 ng/mL)可诱导 PGHS-2 同工型的表达,但肿瘤坏死因子α(TNFα,300 ng/mL)则不能。Manoalide 和 scalaradial(1 - 10 μM)抑制 LPS 诱导的内源性 PGE2 产生,降低 LPS 诱导的 PGHS 活性,并减少 PGHS-2 的表达。吲哚美辛[一种 PGHS 抑制剂(0.01 至 0.1 μM)]、齐留通[一种 5-脂氧合酶抑制剂(3 - 10 μM)]和 WEB-2806[一种血小板活化因子(PAF)拮抗剂(30 μM)]不影响 LPS 诱导的人单核细胞中 PGHS-2 的表达。这些结果表明,manoalide 或 scalaradial 对脂质介质产生的调节可能与观察到的对 PGHS-2 表达的影响无关。Manoalide 和 scalaradial 还抑制 LPS 刺激的单核细胞释放 IL-1β和 TNFα。LPS 或 IL-1β诱导的 PGHS-2 表达被 IL-1 受体拮抗剂(IL-1ra,2 μg/mL)阻断,但不被罗利普兰阻断,罗利普兰是一种磷酸二酯酶 IV 抑制剂,可抑制 TNFα释放但不抑制 IL-1β释放。与 LPS 相似,用特异性抑制剂和拮抗剂确定,IL-1β诱导的 PGHS-2 表达显然不受前列腺素、白三烯或 PAF 等脂质介质的调节。Scalaradial 和在一定程度上 manoalide 能够阻断 IL-1β诱导的 PHGS-2 表达。这些结果表明,IL-1β是负责诱导人单核细胞中 PGHS-2 的主要细胞因子。此外,scalaradial 等海洋天然产物对人单核细胞中 IL-1β介导的 PGHS-2 诱导具有新的作用,这似乎与对脂质介质产生的影响无关。